| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.08 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.061 | 0.08 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.08 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.056 | 0.09 |